Central Research Laboratory

The Central Research Lab (CRL) is engaged in research which is at the interface of nanobiomaterials and biotechnology. CRL aims to empower and enable scientists and doctors in pursuing biomedical research and innovations that will benefit society. The major focus of CRL research is development of new nanomaterials as well as platforms for diagnosis and treatment of various ailments including cancer, submucosal fibrosis and noninvasive prenatal prognosis. CRL is also involved in developing clinically important technologies for Covid-19 and wound dressing material for reducing nosocomial infections.